Generally, EMT is affected by TGFβ and WNT signaling pathways and TGFβ pathway is well-established as a strong inducer of EMT in colon cancer cells (14), glioblastoma (40), and breast cancer (34). This evidence concerns the gene TGFB1 and breast carcinoma.